A Phase III Study for the Treatment of Children and Adolescents With Newly Diagnosed Low Risk Hodgkin Disease

This phase III trial is studying how well combination chemotherapy works when given before
radiation therapy and/or additional chemotherapy in treating young patients with newly
diagnosed Hodgkin's lymphoma. Drugs used in chemotherapy work in different ways to stop the
growth of cancer cells, either by killing the cells or by stopping them from dividing.
Radiation therapy uses high-energy x-rays to kill cancer cells. Giving more than one drug
(combination chemotherapy) and giving them together with radiation therapy may kill more
cancer cells.